Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
Ran Huo, Yanlin Chen, Jie Li, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1818-1830
Open Access | Times Cited: 12

Showing 12 citing articles:

Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access | Times Cited: 2
Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
Weizheng Zhang, Xiaosong Xu, Liping Cai, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Echinacea purpurea polysaccharide intervene in hepatocellular carcinoma via modulation of gut microbiota to inhibit TLR4/NF-κB pathway
Gaoxiang Jing, Wenqian Xu, Wei Ma, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129917-129917
Closed Access | Times Cited: 14
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 12
The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto
Life (2024) Vol. 14, Iss. 2, pp. 239-239
Open Access | Times Cited: 10
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati‐Baroni, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1427-1427
Open Access | Times Cited: 13
Stigmasterol: Remodeling gut microbiota and suppressing tumor growth through Treg and CD8+ T cells in hepatocellular carcinoma
Ran Huo, Wenjing Yang, Yu Liu, et al.
Phytomedicine (2023) Vol. 129, pp. 155225-155225
Closed Access | Times Cited: 11
Effects of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis
Yuting Wang, Youwei Zheng, Lirun Kuang, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 11, pp. 1029-1042
Open Access | Times Cited: 9
Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Ran Qin, Tianqiang Jin, Feng Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2999-2999
Open Access | Times Cited: 7
Research Progress in Intestinal Flora and Hepatocellular Carcinoma
Shuhui Wan, Yong Li
Journal of Biosciences and Medicines (2023) Vol. 11, Iss. 11, pp. 141-150
Open Access
Page 1

Scroll to top